ArticleBMC ophthalmology2021
The microbiologic spectrum of dacryocystitis.
Article in BMC ophthalmology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 43 citations in OpenAlex.
- Epiphora: A Structured Diagnostic Approach for the Otolaryngologist.World journal of otorhinolaryngology - head and neck surgery · 2026Review
- Acute dacryocystitis: Microbiological profiles from an infectious diseases perspective.International ophthalmology · 2026Article
- Risk Factors and Clinical Outcomes of Secondary Infection in Congenital Dacryocystocele.Ophthalmology and therapy · 2026Article
- Evaluation of the clinical efficacy of endoscopic endonasal dacryocystorhinostomy in treating chronic dacryocystitis.Frontiers in medicine · 2026Article
- Overview of Microorganisms: Bacterial Microbiome, Mycobiome, Virome Identified Using Next-Generation Sequencing, and Their Application to Ophthalmic Diseases.Microorganisms · 2025Review
- Bacterial Diversity in Pet Rabbits: Implications for Public Health, Zoonotic Risks, and Antimicrobial Resistance.Microorganisms · 2025Article
- Microbiological spectrum and antibiotic susceptibility analysis of secretion from 308 cases of chronic dacryocystitis in north China.International journal of ophthalmology · 2025Article
- Bibliometric and visualized analysis of research hotpots and future prospects in lacrimal duct obstruction disease (1900 to 2024).International journal of ophthalmology · 2025Article
- Microbiology of acute bacterial dacryocystitis: a tertiary institutional experience in South Australia.International ophthalmology · 2024Article
- Clinical characteristics and cytological changes in mucinous obstruction diagnosed by dacryoendoscopy.Scientific reports · 2024Article
- scRNA-Seq: First Atlas and Cellular Landscape of Lacrimal Sac: Implications in Primary Acquired Nasolacrimal Duct Obstruction Pathogenesis.Investigative ophthalmology & visual science · 2024Article
- The epidemiology and the pathogen distribution of pediatric dacryocystitis in Chinese population 2017-2022.Italian journal of pediatrics · 2024Article
- Microbiology and Antimicrobial Susceptibility in Adult Dacryocystitis.Clinical ophthalmology (Auckland, N.Z.) · 2024Article
- Treatment of acute dacryocystitis by translacrimal canalicular drainage and D-silicone intubation.International journal of ophthalmology · 2024Article
- Endoscopic dacryocystorhinostomy in acute dacryocystitis: a multicenter study in China.International journal of ophthalmology · 2024Article
- Five-year analysis of isolated pathogens and antibiotic resistance of ocular infections from two large tertiary comprehensive hospitals in east China.International journal of ophthalmology · 2024Article
- A case report of chronic dacryocystitis caused by nasal stones.BMC ophthalmology · 2023Article
- Pediatric Acute Dacryocystitis and Orbital Cellulitis With Concurrent COVID-19 Infection: A Case Report.Cureus · 2023Article
- The influence of microorganisms on early relapses after external dacryocystorhinostomy.International ophthalmology · 2023Article
- Ocular Bacterial Infections: A Ten-Year Survey and Review of Causative Organisms Based on the Oklahoma Experience.Microorganisms · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo investigate the microbiologic spectrum of dacryocystitis in adult and pediatric groups, specifically the microbiologic differences between chronic dacryocystitis with nasolacrimal duct obstruction (NLDO) and acute dacryocystitis in pediatric group.
methodsThis retrospective study was reviewed for demographic and microbiologic profile of dacryocystitis. The culture results were reported.
resultsSixty-four adults and one hundred and five pediatrics with dacryocystitis were included in this study. Of all adults, only chronic dacryocystitis with NLDO was observed. Of all pediatric patients, 89 had chronic dacryocystitis with NLDO and 16 had acute dacryocystitis. Gram positive and negative isolates were numerically equal in adult group (both 36(48.65%)), while gram positive isolates were the major organism in pediatric group (71(58.68%)). Streptococcus pneumonia was the most common isolate in both adult (11(14.86%)) and pediatric (30(24.79%)) dacryocystitis. For both pediatric subgroups, gram positive isolates were the major organism (59(57.84%) for chronic dacryocystitis with NLDO and 12 (63.16%) for acute dacryocystitis). However, the leading isolates in those two subgroups were distinct, with Streptococcus pneumonia (29(28.43%)) being most common in chronic dacryocystitis with NLDO and Staphylococcus aureus (8(42.11%)) being most common in acute dacryocystitis.
conclusionsIn adult group, gram negative isolates were more common in dacryocystitis than before. In pediatric group, gram positive isolates were still the major infection pathogen. Moreover, the more virulent organisms were more common in acute dacryocystitis than chronic dacryocystitis with NLDO.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.